IP Library Granted Patent US 9,555,068
Granted Patent B2
US 9,555,068 · App. 14/489,731 · Granted Jan 31, 2017

Oral compositions and route of administration for the delivery of a thylakoid extract

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,555,068
App. No.
14/489,731
Granted
Jan 31, 2017
Kind
B2
Abstract

A new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Also described is a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract. Also described is an oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consist of water, physiological saline or propylene glycol. The thylakoid extract or composition is also provided as a food or a food supplement, or as a pellet, or encapsulated granules or powder.

Claims (8)

1. A method of treating inflammation in a patient in need thereof, comprising, orally administering to said patient an oral composition in an effective amount to treat inflammation, the oral composition including a purified thylakoid extract and a carrier comprising sodium alginate, CMC low viscosity or CMC high viscosity.

2. The method of claim 1 , further comprising, administering said oral composition to said patient to provide the purified thylakoid extract at a dosage of 0.1 to 10 mg per Kg of body weight of said patient.

3. The method of claim 2 , further comprising, administering said oral composition to said patient to provide the oral composition in liquid form.

4. The method of claim 2 , further comprising, administering said oral composition to said patient to provide the oral composition in solid form.

5. The method of claim 4 , wherein said administration of the oral composition in solid form is selected from the group consisting of: pellets, powder, granules and capsules.

6. The method of claim 1 , wherein said purified thylakoid extract of said oral composition is defined by a ratio chlorophyll/carotene of at least 4.

7. The method of claim 6 , wherein said purified thylakoid extract of said oral composition is defined by a ratio chlorophyll/carotene of about 5.

8. The method of claim 1 , wherein said purified thylakoid extract or said oral composition comprises a photosynthetic activity defined by a ratio Fv/Fm of at least 0.4.

Assignments (7)
SECURITY INTEREST Recorded Feb 23, 2024
From: DEVONIAN HEALTH GROUP INC.
To: FIERA PRIVATE DEBT INC.
Reel/Frame 066539/0690 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2024
From: GRX HEALTHCARE INC.
To: GROUPE SANTÉ DEVONIAN INC.
Reel/Frame 066287/0652 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REVERSING ASSIGNOR AND ASSIGNEE INFORMATION PREVIOUSLY RECORDED AT REEL: 49895 FRAME: 301. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 30, 2021
From: INVESTISSEMENT QUÉBEC
To: GROUPE SANTÉ DEVONIAN INC.
Reel/Frame 057688/0869 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 16154364 PREVIOUSLY RECORDED AT REEL: 048359 FRAME: 0174. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 28, 2021
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 057292/0433 →
RELEASE OF SECURITY INTEREST Recorded Jul 29, 2019
From: GROUPE SANTÉ DEVONIAN INC.
To: INVESTISSEMENT QUÉBEC
Reel/Frame 049895/0301 →
SECURITY INTEREST Recorded Feb 18, 2019
From: DEVONIAN HEALTH GROUP INC.
To: GRX HEALTHCARE INC.
Reel/Frame 048359/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2015
From: PURGENESIS TECHNOLOGIES INC.
To: GROUPE SANTÉ DEVONIAN
Reel/Frame 035424/0029 →